Sporadic and endemic Burkitt lymphoma have frequent


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
23 07 2019
Historique:
received: 06 12 2018
accepted: 14 04 2019
entrez: 14 7 2019
pubmed: 14 7 2019
medline: 8 7 2020
Statut: ppublish

Résumé

FOXO1 has an oncogenic role in adult germinal center-derived lymphomas, in which mutations, predominately within the AKT recognition motif, cause nuclear retention of FOXO1, resulting in increased cell proliferation. To determine the prevalence and distribution of

Identifiants

pubmed: 31300419
pii: bloodadvances.2018029546
doi: 10.1182/bloodadvances.2018029546
pmc: PMC6650741
doi:

Substances chimiques

ARID1A protein, human 0
DNA-Binding Proteins 0
FOXO1 protein, human 0
Forkhead Box Protein O1 0
Transcription Factors 0
Proto-Oncogene Proteins c-akt EC 2.7.11.1
DDX3X protein, human EC 3.6.1.-
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2118-2127

Subventions

Organisme : Blood Cancer UK
ID : 12005
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom

Informations de copyright

© 2019 by The American Society of Hematology.

Références

Immunity. 2015 Dec 15;43(6):1064-74
pubmed: 26620759
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Cancer Cell. 2013 Jun 10;23(6):826-38
pubmed: 23764004
Nat Genet. 2012 Dec;44(12):1316-20
pubmed: 23143595
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
N Engl J Med. 2018 Apr 12;378(15):1396-1407
pubmed: 29641966
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Cell. 2017 Nov 2;171(4):824-835.e18
pubmed: 29056338
J Hematol Oncol. 2017 Mar 17;10(1):70
pubmed: 28302137
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Clin Cancer Res. 2017 May 1;23(9):2232-2244
pubmed: 27923841
Semin Cancer Biol. 2018 Jun;50:90-100
pubmed: 29175105
Clin Cancer Res. 2016 May 1;22(9):2290-300
pubmed: 26647218
Cell Mol Life Sci. 2016 Mar;73(6):1159-72
pubmed: 26686861
Br J Haematol. 2017 Jun;177(6):984-990
pubmed: 27891583
Blood. 2018 Dec 20;132(25):2670-2683
pubmed: 30333121
Br J Haematol. 2008 Jun;141(6):840-7
pubmed: 18371107
J Med Genet. 2011 Feb;48(2):123-30
pubmed: 21037276
Nat Genet. 2012 Dec;44(12):1321-5
pubmed: 23143597
Cancer Cell. 2012 Aug 14;22(2):167-79
pubmed: 22897848
Nature. 2012 Oct 4;490(7418):116-20
pubmed: 22885699
Leukemia. 2018 Mar;32(3):675-684
pubmed: 28804123
J Mol Diagn. 2018 Mar;20(2):203-214
pubmed: 29429887
Semin Cancer Biol. 2018 Jun;50:53-64
pubmed: 29309928
Semin Cancer Biol. 2018 Jun;50:132-141
pubmed: 28774833
Cold Spring Harb Perspect Med. 2014 Feb 01;4(2):
pubmed: 24492847
PLoS Pathog. 2015 Oct 15;11(10):e1005158
pubmed: 26468873
Mol Cancer Res. 2017 May;15(5):563-576
pubmed: 28465297
Oncoimmunology. 2018 Jan 25;7(5):e1423183
pubmed: 29721381
Cell. 2017 Oct 5;171(2):481-494.e15
pubmed: 28985567
Biomed Res Int. 2014;2014:925350
pubmed: 24864265
Blood. 2019 Mar 21;133(12):1313-1324
pubmed: 30617194
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Ann Trop Paediatr. 2009 Mar;29(1):29-34
pubmed: 19222931
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Blood. 2007 Apr 1;109(7):2773-80
pubmed: 17132719
Biochim Biophys Acta. 2011 Nov;1813(11):1938-45
pubmed: 21708191
Blood. 2007 Apr 1;109(7):2736-43
pubmed: 17138821
Immunity. 2015 Dec 15;43(6):1075-86
pubmed: 26620760
Blood. 2013 May 2;121(18):3666-74
pubmed: 23460611
Clin Cancer Res. 2016 Jun 15;22(12):2919-28
pubmed: 26819451
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147

Auteurs

Peixun Zhou (P)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

Alex E Blain (AE)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

Alexander M Newman (AM)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

Masood Zaka (M)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

George Chagaluka (G)

Department of Paediatrics, College of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.

Filbert R Adlar (FR)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

Ugonna T Offor (UT)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
Department of Paediatric and Adolescent Haematology and Oncology, The Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Casey Broadbent (C)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

Lewis Chaytor (L)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

Amber Whitehead (A)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

Amy Hall (A)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

Hettie O'Connor (H)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

Susan Van Noorden (S)

Department of Histopathology, Imperial College London, Hammersmith Hospital, London, United Kingdom.

Irvin Lampert (I)

Department of Histopathology, West Middlesex University Hospital, Isleworth, United Kingdom; and.

Simon Bailey (S)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
Department of Paediatric and Adolescent Haematology and Oncology, The Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Elizabeth Molyneux (E)

Department of Paediatrics, College of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.

Chris M Bacon (CM)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Simon Bomken (S)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
Department of Paediatric and Adolescent Haematology and Oncology, The Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Vikki Rand (V)

Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH